Mirxes Holding Company Limited
Status: Publicly traded
Direct answer
Mirxes Holding Company Limited is publicly traded on HKSE under the ticker 2629.HK.
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and...
Can you invest in Mirxes Holding Company Limited?
Yes. Mirxes Holding Company Limited is publicly traded on HKSE under the ticker 2629.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mirxes Holding Company Limited
Detailed equity research is provided by MarketSnap.